Izba

Travoprost, the active ingredient in Izba, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It works by increasing uveoscleral outflow of aqueous humor, thereby reducing intra‑ocular pressure. The medication is indicated for adults diagnosed with primary open‑angle glaucoma or ocular hypertension.

GNH USA supplies Izba as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide, and supporting global procurement needs with regulatory expertise and reliable logistics.

Travoprost is a prostaglandin analog used to manage conditions characterized by elevated intra‑ocular pressure.

- Primary open-angle glaucoma: reduces intra‑ocular pressure to slow disease progression. - Ocular hypertension: lowers intra‑ocular pressure to prevent development of glaucoma. - Normal‑tension glaucoma: helps maintain target pressure to protect optic nerve health.

Travoprost may cause ocular and systemic reactions.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Eye irritation: burning or stinging sensation after instillation. - Blurred vision: transient visual disturbance. - Increased eyelash growth: longer, thicker lashes. - Darkening of iris: gradual pigmentation change. - Eye pain: mild discomfort.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, rash, or difficulty breathing. - Uveitis: inflammation of the uveal tract. - Macular edema: swelling of the central retina. - Vision loss: sudden decrease in visual acuity. - Ocular infection: signs of bacterial or fungal infection.

When prescribing Travoprost, consider the following safety measures.

- Pregnancy: safety not established; avoid unless benefits outweigh risks. - Breastfeeding: unknown excretion; consider potential infant exposure. - Contraindications: active ocular infection or inflammation. - Monitoring: check intra‑ocular pressure regularly after starting therapy. - Contact lens wearers: remove lenses before instillation and wait before reinserting. - Store at room temperature: keep bottle in original container, protect from light and moisture.

Travoprost may interact with other ocular or systemic agents.

Major Interactions (Avoid): - Concomitant prostaglandin analog eye drops: increased risk of ocular adverse effects. - Non‑steroidal anti‑inflammatory eye drops: may reduce Travoprost efficacy. - Systemic carbonic anhydrase inhibitors: additive intra‑ocular pressure lowering, requiring close monitoring.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: additive pressure reduction, monitor IOP. - Corticosteroid eye drops: may diminish Travoprost's IOP‑lowering effect. - Alpha‑agonist eye drops: possible additive effect on pressure reduction.